Endometriosis: Recent Advances
Author: Dr. Sharad Maheshwari MD • imagingsimplified@gmail.com
High-yield revision capsule covering the shift from anatomical to molecular paradigms, new biomarkers, ENZIAN staging, and targeted therapies.
A 32-year-old nulliparous woman presents with a 10-year history of worsening dysmenorrhea, chronic non-cyclic pelvic pain, and deep dyspareunia. She has struggled to conceive for 3 years. Over-the-counter NSAIDs provide minimal relief.
Clinical Reasoning: This constellation of symptoms—cyclical pain, non-cyclical pain, site-specific pain (dyspareunia), and infertility—is the classic hallmark of endometriosis, demanding a comprehensive diagnostic and therapeutic strategy.
Pathophysiology & Core Mechanisms
Cyclical Hemorrhage
Ectopic endometrial tissue responds to hormones, bleeding locally during menstruation.
Chronic Inflammation
Accumulated blood products trigger severe local and systemic immune dysfunction.
Fibrosis & Tethering
Dense stromal components cause architectural distortion, adhesions, and organ tethering.
Evidence Base: Interplay of hemorrhage, inflammation, and fibrosis is central to pathogenesis. Taylor et al., "Endometriosis is a chronic systemic disease" (Lancet, 2021).
Clinical Presentation & Exam
Site-Specific Symptoms
- Deep Dyspareunia: Pouch of Douglas/Uterosacral involvement.
- Dyschezia: Rectosigmoid invasion (Deep Endometriosis).
- Dysuria / Hematuria: Bladder/ureteral involvement.
Key Exam Findings
- Fixed, retroverted uterus.
- Nodularity in posterior cul-de-sac.
- Tenderness along uterosacral ligaments.
Biomarker Note: Serum CA-125 may be elevated but lacks diagnostic specificity.
Evidence Base: Detailed clinical examination guides subsequent imaging. ACOG Practice Bulletin No. 114 (Reaffirmed 2022).
High-Yield Concept Paradigm
Old Paradigm
- Disease: Purely Anatomical
- Diagnosis: Laparoscopy (Gold Standard)
New Paradigm (2026)
- Disease: Molecular + Inflammatory + Fibrotic + Genetic
- Diagnosis: Biomarkers + MRI + Molecular Imaging
Evidence Base: The shift towards recognizing endometriosis as a systemic, molecular disease is extensively supported in recent literature. Taylor et al., "Endometriosis is a chronic systemic disease" (Lancet, 2021).
1. Genetics (Recent Advances)
Susceptibility Genes
- WNT4 (Strongest association)
- GREB1
- VEZT
- IL1A, FSHB
Somatic Mutations in Lesions
Exam Pearl
Endometriosis is now considered a clonal disease with cancer-like mutations despite being benign.
Evidence Base (Genetics):
- WNT4 Association: Nyholt et al. (Nat Genet) / GWAS meta-analyses.
- KRAS & ARID1A Somatic Mutations: "KRAS mutations and endometriosis burden of disease" (PMC10240146) & ARID1A Mutations in Endometriosis (PMC3794809) validating the clonal nature of the disease.
2. Salivary microRNA Test
Ziwig Endotest®
(France)
Uses
Saliva sample
109 miRNA panel
AI-based analysis
Performance
Sensitivity >97%
Specificity >93%
Evidence Base: The ENDOmiRNA study validated the high sensitivity/specificity of the 109-miRNA salivary signature. Recent Clinical Validation Study of Salivary miRNA for Endometriosis (PubMed: 41147827).
3. Imaging & Nuclear Medicine
TVUS
First-line imaging. Best for:
- Endometrioma
- Deep infiltrating endometriosis (DIE)
MRI
Best for mapping & surgery. Detects:
- Bowel & Bladder involvement
- Ureteric & Pelvic sidewall disease
New Nuclear Scans
99mTc-Maraciclatide SPECT-CT
Target: αvβ3 integrin & Angiogenesis
Detects: Active lesions, Superficial peritoneal disease
FAPI PET (Research)
Target: Activated fibroblasts
Used for: Assessing fibrotic disease burden
Evidence Base (Molecular Imaging):
- 99mTc-Maraciclatide: Safety & biodistribution (PMC10916747) & the landmark DETECT study (The Lancet Obstetrics, Gynaecology & Women's Health, 2026) for SPE mapping.
- FAPI PET: Sandler et al., "68 Ga-FAPI-04 PET/CT Demonstrates Subtype-specific Uptake Patterns in Endometriosis" (Clin Nucl Med, May 2026).
ENZIAN for Radiologists
For radiologists, the challenge with ENZIAN isn't remembering A-B-C, but recalling the extended compartments (O, T, FA, FB, FU, FI, FN). Here is a layered memory mastery approach.
Level 1: The Main Disease Map
Area between vagina & rectum.
(Rectovaginal septum, Vagina)
Posterior supports.
(Torus uterinus, Uterosacral ligaments, Pelvic sidewall)
Bowel involvement.
(Rectum, Rectosigmoid)
Ultra-Short Mnemonic
"A Big Colon Occupies Tubes; FA, FB, FU, FI, FN."
The easiest sequence to recall while actively dictating a report.
Alternative Sentence
"A Big Colon Often Traps Adenomyosis, Bladder, Ureter, Intestine and Nerves."
Medical & Surgical Management
Medical Foundations
- NSAIDs: First-line for pain management prior to hormonal therapy.
- Progestins: e.g., Dienogest. Highly effective for long-term symptom suppression.
- GnRH Agonists: Require "add-back therapy" to mitigate bone mineral density loss and menopausal symptoms.
Surgical & Adjuncts
- Laparoscopy: Gold standard. Excision of lesions, adhesiolysis, and restoration of anatomy.
- Fertility-Sparing: Prioritized in patients desiring conception.
- Multidisciplinary Care: Pelvic floor physical therapy, psychology, and centralized pain management.
Most Important Recent Drug Class
Oral GnRH Antagonists
Evidence Base (Management):
- Guidelines: ACOG Practice Bulletin No. 114 & ESHRE 2022 Guidelines support NSAIDs and Dienogest as first-line.
- Elagolix: Taylor et al., "Treatment of Endometriosis-Associated Pain with Elagolix" (NEJM, 2017).
Prognosis & Complications
Ovarian Cancer Risk
Endometriomas are associated with an increased risk of developing clear cell and endometrioid ovarian carcinomas. This is thought to be driven by chronic inflammation and accumulation of cancer driver mutations (e.g., ARID1A, PIK3CA).
Structural & Functional Complications
- Infertility: Most common complication, caused by anatomical distortion (adhesions) and hostile inflammatory milieu.
- Ureteral Compression: Deep infiltrating lesions can cause strictures, hydronephrosis, and eventually chronic kidney disease.
- Bowel Obstruction: Secondary to severe fibrotic tethering.
Evidence Base: Established epidemiological links exist between endometriosis and specific ovarian cancer subtypes. Kvaskoff et al., "Endometriosis: a high-risk population for major chronic diseases?" (Lancet Psychiatry/Oncol, 2021).
7. Future Precision Medicine Model
ENZIAN DIE Calculator
Select lesion sizes to generate ENZIAN string. Superior to rASRM for Deep Infiltrating Endometriosis, as rASRM fails to quantify retroperitoneal, bowel, and bladder disease.
Revision Table
| Strongest genetic link | WNT4 |
|---|---|
| Salivary test | Ziwig Endotest |
| Mapping MRI Class. | ENZIAN |
| New nuclear scan | 99mTc-Maraciclatide |
| Maraciclatide target | αvβ3 integrin |
| 1st oral GnRH antag. | Elagolix |
| Common mutations | KRAS, ARID1A, PIK3CA, PTEN |
High-Yield Flashcards
Click to flip and memorize key concepts.
Memory Trick
W-M-E-M-E
Tap to reveal
- W = WNT4 (Genetics)
- M = miRNA saliva test
- E = ENZIAN MRI staging
- M = Maraciclatide scan
- E = Elagolix treatment
Most promising salivary biomarker?
Ziwig Endotest
99mTc-Maraciclatide targets which receptor?
αvβ3 integrin
First oral GnRH antagonist approved?
Elagolix
Most widely used MRI classification for DIE?
ENZIAN
Endometriosis Q-Bank
NEET PG / INI-CET Pattern MCQs (2026 Updates included)
Comments
Post a Comment